Certain lots of the Certitude Delivery System of the Sapien 3 transcatheter heart valve are under class I recall due to a molding overflow defect within the loader. (FDA MedWatch)
Researchers found that mortality was lower at 1 year for those who got cardiac revascularization in England versus New York State — yet adjusted costs were four times higher in the latter. (Open Heart)
Drug-coated balloons maintained their superiority over standard percutaneous transluminal angioplasty in femoropopliteal arteries at 3-years in the IN.PACT SFA trial. Functional outcomes and rates of primary patency and clinically-driven target lesion revascularization all favored the balloons over standard angioplasty. (Circulation: Cardiovascular Interventions)
Atrial fibrillation patients who got pulmonary vein isolation under the CLOSE protocol were more likely to be free of atrial tachyarrhythmia within a year than were those who got conventional contact force-guided ablation, according to a small observational study published in EP Europace. CLOSE ablations, with region-specific criteria for lesion contiguity and lesion depth, may also take less time.
When non-culprit lesions were left unstented after percutaneous coronary intervention for an MI, they carried double the risk of causing a recurrent MI when compared with initially-stented culprit lesions. (Journal of the American Heart Association)
The Casper double-layer carotid stent was deployed successfully in all 138 cases of occlusive disease in the carotid artery attempted. The stent, used along with a distal embolic protection device, was associated with zero major adverse neurological events within 90 days, according to a paper in the Journal of NeuroInterventional Surgery.
Transfemoral transcatheter aortic valve replacement bested surgery for 30-day stroke and mortality in real-world experience of intermediate-risk patients treated at the Minneapolis VA Healthcare System. (Catheterization and Cardiovascular Interventions)